IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v14y2023i1d10.1038_s41467-023-41028-9.html
   My bibliography  Save this article

MAVS integrates glucose metabolism and RIG-I-like receptor signaling

Author

Listed:
  • Qiao-qiao He

    (Wuhan University)

  • Yu Huang

    (Wuhan University)

  • Longyu Nie

    (Wuhan University)

  • Sheng Ren

    (Wuhan University)

  • Gang Xu

    (Wuhan University)

  • Feiyan Deng

    (Wuhan University)

  • Zhikui Cheng

    (Wuhan University)

  • Qi Zuo

    (Wuhan University)

  • Lin Zhang

    (Wuhan University
    Zhongnan Hospital of Wuhan University)

  • Huanhuan Cai

    (Wuhan University
    Zhongnan Hospital of Wuhan University)

  • Qiming Wang

    (Hunan Agricultural University)

  • Fubing Wang

    (Chinese Academy of Medical Sciences)

  • Hong Ren

    (Affiliated Hospital to Shanghai Jiao Tong University School of Medicine)

  • Huan Yan

    (Wuhan University)

  • Ke Xu

    (Wuhan University)

  • Li Zhou

    (Wuhan University)

  • Mengji Lu

    (University Hospital Essen, University of Duisburg-Essen)

  • Zhibing Lu

    (Wuhan University
    Zhongnan Hospital of Wuhan University)

  • Ying Zhu

    (Wuhan University)

  • Shi Liu

    (Wuhan University
    Wuhan University
    Hunan Agricultural University
    Chinese Academy of Medical Sciences)

Abstract

MAVS is an adapter protein involved in RIG-I-like receptor (RLR) signaling in mitochondria, peroxisomes, and mitochondria-associated ER membranes (MAMs). However, the role of MAVS in glucose metabolism and RLR signaling cross-regulation and how these signaling pathways are coordinated among these organelles have not been defined. This study reports that RLR action drives a switch from glycolysis to the pentose phosphate pathway (PPP) and the hexosamine biosynthesis pathway (HBP) through MAVS. We show that peroxisomal MAVS is responsible for glucose flux shift into PPP and type III interferon (IFN) expression, whereas MAMs-located MAVS is responsible for glucose flux shift into HBP and type I IFN expression. Mechanistically, peroxisomal MAVS interacts with G6PD and the MAVS signalosome forms at peroxisomes by recruiting TNF receptor-associated factor 6 (TRAF6) and interferon regulatory factor 1 (IRF1). By contrast, MAMs-located MAVS interact with glutamine-fructose-6-phosphate transaminase, and the MAVS signalosome forms at MAMs by recruiting TRAF6 and TRAF2. Our findings suggest that MAVS mediates the interaction of RLR signaling and glucose metabolism.

Suggested Citation

  • Qiao-qiao He & Yu Huang & Longyu Nie & Sheng Ren & Gang Xu & Feiyan Deng & Zhikui Cheng & Qi Zuo & Lin Zhang & Huanhuan Cai & Qiming Wang & Fubing Wang & Hong Ren & Huan Yan & Ke Xu & Li Zhou & Mengji, 2023. "MAVS integrates glucose metabolism and RIG-I-like receptor signaling," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
  • Handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-41028-9
    DOI: 10.1038/s41467-023-41028-9
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-023-41028-9
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-023-41028-9?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Dara L. Burdette & Kathryn M. Monroe & Katia Sotelo-Troha & Jeff S. Iwig & Barbara Eckert & Mamoru Hyodo & Yoshihiro Hayakawa & Russell E. Vance, 2011. "STING is a direct innate immune sensor of cyclic di-GMP," Nature, Nature, vol. 478(7370), pages 515-518, October.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Martha Triantafilou & Joshi Ramanjulu & Lee M. Booty & Gisela Jimenez-Duran & Hakan Keles & Ken Saunders & Neysa Nevins & Emma Koppe & Louise K. Modis & G. Scott Pesiridis & John Bertin & Kathy Triant, 2022. "Human rhinovirus promotes STING trafficking to replication organelles to promote viral replication," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    2. Rana Falahat & Anders Berglund & Patricio Perez-Villarroel & Ryan M. Putney & Imene Hamaidi & Sungjune Kim & Shari Pilon-Thomas & Glen N. Barber & James J. Mulé, 2023. "Epigenetic state determines the in vivo efficacy of STING agonist therapy," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
    3. Bao-cun Zhang & Marlene F. Laursen & Lili Hu & Hossein Hazrati & Ryo Narita & Lea S. Jensen & Aida S. Hansen & Jinrong Huang & Yan Zhang & Xiangning Ding & Maimaitili Muyesier & Emil Nilsson & Agniesz, 2024. "Cholesterol-binding motifs in STING that control endoplasmic reticulum retention mediate anti-tumoral activity of cholesterol-lowering compounds," Nature Communications, Nature, vol. 15(1), pages 1-17, December.
    4. Matteo Gentili & Bingxu Liu & Malvina Papanastasiou & Deborah Dele-Oni & Marc A. Schwartz & Rebecca J. Carlson & Aziz M. Al’Khafaji & Karsten Krug & Adam Brown & John G. Doench & Steven A. Carr & Nir , 2023. "ESCRT-dependent STING degradation inhibits steady-state and cGAMP-induced signalling," Nature Communications, Nature, vol. 14(1), pages 1-22, December.
    5. Xia Li & Wenfang Yin & Junjie Desmond Lin & Yong Zhang & Quan Guo & Gerun Wang & Xiayu Chen & Binbin Cui & Mingfang Wang & Min Chen & Peng Li & Ya-Wen He & Wei Qian & Haibin Luo & Lian-Hui Zhang & Xue, 2023. "Regulation of the physiology and virulence of Ralstonia solanacearum by the second messenger 2′,3′-cyclic guanosine monophosphate," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    6. Manas Sharma & Trason Thode & Alexis Weston & Mohan R Kaadige, 2018. "HematologicalDevelopment of Enpp1 Inhibitors as a Strategy to Activate Stimulator of Interferon Genes (STING) in Cancers and Other Diseases," International Journal of Cell Science & Molecular Biology, Juniper Publishers Inc., vol. 5(1), pages 24-28, September.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-41028-9. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.